Your browser doesn't support javascript.
loading
Systemic Right Ventricle in Adults With Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management.
Brida, Margarita; Diller, Gerhard-Paul; Gatzoulis, Michael A.
Afiliação
  • Brida M; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom (M.B., G.-P.D., M.A.G.).
  • Diller GP; Department of Cardiovascular Medicine, Division of Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Germany (M.B., G.-P.D.).
  • Gatzoulis MA; Department of Cardiovascular Medicine, Division of Adult Congenital Heart Disease, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Croatia (M.B.).
Circulation ; 137(5): 508-518, 2018 01 30.
Article em En | MEDLINE | ID: mdl-29378757
ABSTRACT
The systemic right ventricle (SRV) is commonly encountered in congenital heart disease representing a distinctly different model in terms of its anatomic spectrum, adaptation, clinical phenotype, and variable, but overall guarded prognosis. The most common clinical scenarios where an SRV is encountered are complete transposition of the great arteries with previous atrial switch repair, congenitally corrected transposition of the great arteries, double inlet right ventricle mostly with previous Fontan palliation, and hypoplastic left heart syndrome palliated with the Norwood-Fontan protocol. The reasons for the guarded prognosis of the SRV in comparison with the systemic left ventricle are multifactorial, including distinct fibromuscular architecture, shape and function, coronary artery supply mismatch, intrinsic abnormalities of the tricuspid valve, intrinsic or acquired conduction abnormalities, and varied SRV adaptation to pressure or volume overload. Management of the SRV remains an ongoing challenge because SRV dysfunction has implications on short- and long-term outcomes for all patients irrespective of underlying cardiac morphology. SRV dysfunction can be subclinical, underscoring the need for tertiary follow-up and timely management of target hemodynamic lesions. Catheter interventions and surgery have an established role in selected patients. Cardiac resynchronization therapy is increasingly used, whereas pharmacological therapy is largely empirical. Mechanical assist device and heart transplantation remain options in end-stage heart failure when other management strategies have been exhausted. The present report focuses on the SRV with its pathological subtypes, pathophysiology, clinical features, current management strategies, and long-term sequelae. Although our article touches on issues applicable to neonates and children, its main focus is on adults with SRV.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardioversão Elétrica / Cateterismo Cardíaco / Função Ventricular Direita / Disfunção Ventricular Direita / Terapia de Ressincronização Cardíaca / Cardiopatias Congênitas / Procedimentos Cirúrgicos Cardíacos / Ventrículos do Coração Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardioversão Elétrica / Cateterismo Cardíaco / Função Ventricular Direita / Disfunção Ventricular Direita / Terapia de Ressincronização Cardíaca / Cardiopatias Congênitas / Procedimentos Cirúrgicos Cardíacos / Ventrículos do Coração Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article